U
PDL BioPharma, Inc. PDLIV
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$1.59
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$19.73M
EBITDA (TTM)
-$31.06M
EBIT (TTM)
-$33.44M
Net Income (TTM)
-$136.58M
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
-$51.23M
Cash from Investing (TTM)
$45.46M
Cash from Financing (TTM)
-$163.18M
Net Change in Cash (TTM)
-$168.95M
Filings
Filing Date
Friday, November 13, 2020
Period Date
Wednesday, September 30, 2020
Next Filing
(est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
-- - --
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
115.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pdl.com
Phone Number
775 832 8500
Address
932 Southwood Boulevard
Incline Village, NV 89451
Country
United States
Year Founded
1986
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
PDL BioPharma, Inc., together with its subsidiaries, manages various patents in the United States and internationally. The company’s patents cover humanization of antibodies. It also offers notes... more